This page is informational (RUO)
However, caution should be taken when interpreting these results due to short follow-up periods (i.e., 1.11.4 years [18,19,20]), the possibility of confounding bias caused by the inclusion of advanced T2D cases (i.e., requiring intensive insulin therapy [18]), uncertain liver effects (e.g., incident NAFLD) of active comparators (i.e., DPP4is [19, 20] and insulin [18]), lack of dose-response analysis, and limited generalizability to other ethnic populations
This test answers a fundamental question: is this actually retatrutide
Lin Z, Tang Q, Wu W, et al
Preliminary data suggests similar patterns with Tirzepatide
This potentially illustrates how sex-based differences in the use of GLP-1 medications may influence uveitis risk, highlighting the importance of needing to better approach adults with diabetes regarding eye health, the researchers highlighted in their abstract